Related Experiment Video
Updated: Aug 13, 2025
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.3K
Cardiovascular lesions in giant cell arteritis
Marta Dzhus1,2, Halyna Mostbauer1
1O. Bohomolets National Medical University, Kyiv, Ukraine.
Reumatologia
|January 23, 2023
Summary
Giant cell arteritis (GCA) patients face higher risks of serious cardiovascular events like heart attack and stroke. Early diagnosis and monitoring are crucial, especially within the first year after GCA diagnosis.
Area of Science:
- Rheumatology
- Cardiology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a large-vessel systemic vasculitis.
- Cardiovascular complications in GCA significantly increase morbidity and mortality.
- Understanding these complications is vital for patient prognosis.
Purpose of the Study:
- To review the epidemiology, clinical presentation, etiopathology, and cardiovascular risks associated with GCA.
- To synthesize current knowledge on cardiovascular complications in patients diagnosed with GCA.
Main Methods:
- A comprehensive literature review was conducted from 2002 to 2021.
- Searches were performed in PubMed and Medline using keywords related to GCA and cardiovascular diseases.
- English-language articles were included in the analysis.
Main Results:
- Patients with GCA exhibit an elevated risk of aortic aneurysm, aortic dissection, coronary heart disease, cerebrovascular events, and peripheral artery disease.
- Cardiovascular complications are associated with a worse prognosis in GCA.
- The highest risk for cardiovascular complications occurs within the first year post-GCA diagnosis.
Conclusions:
- GCA patients have an increased susceptibility to cardiovascular diseases, though research findings can be conflicting.
- There is a need for improved understanding and treatment strategies for cardiovascular complications in GCA.
- Vigilant monitoring for potentially fatal cardiovascular outcomes is mandatory for GCA patients.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
27
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
27
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
26
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
01:25Endocarditis II: Clinical Features of Infective Endocarditis
21
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
21
01:30Atherosclerosis I: Introduction
32
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
32
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
43
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
01:26Coronary Artery Disease II: Pathophysiology
22
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22